Your browser doesn't support javascript.
loading
Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia.
Burns, Grace L; Bruce, Jessica K; Minahan, Kyra; Mathe, Andrea; Fairlie, Thomas; Cameron, Raquel; Naudin, Crystal; Nair, Prema M; Potter, Michael D E; Irani, Mudar Zand; Bollipo, Steven; Foster, Robert; Gan, Lay T; Shah, Ayesha; Koloski, Natasha A; Foster, Paul S; Horvat, Jay C; Veysey, Martin; Holtmann, Gerald; Powell, Nick; Walker, Marjorie M; Talley, Nicholas J; Keely, Simon.
Affiliation
  • Burns GL; College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia.
  • Bruce JK; Immune Health Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
  • Minahan K; National Health & Medical Research Council (NHMRC) Centre of Research Excellence in Digestive Health, University of Newcastle, Newcastle, NSW, Australia.
  • Mathe A; College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia.
  • Fairlie T; Immune Health Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
  • Cameron R; National Health & Medical Research Council (NHMRC) Centre of Research Excellence in Digestive Health, University of Newcastle, Newcastle, NSW, Australia.
  • Naudin C; College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia.
  • Nair PM; Immune Health Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
  • Potter MDE; National Health & Medical Research Council (NHMRC) Centre of Research Excellence in Digestive Health, University of Newcastle, Newcastle, NSW, Australia.
  • Irani MZ; College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia.
  • Bollipo S; Immune Health Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
  • Foster R; National Health & Medical Research Council (NHMRC) Centre of Research Excellence in Digestive Health, University of Newcastle, Newcastle, NSW, Australia.
  • Gan LT; Translational Research Institute, Brisbane, QLD, Australia.
  • Shah A; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Koloski NA; College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia.
  • Foster PS; Immune Health Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
  • Horvat JC; National Health & Medical Research Council (NHMRC) Centre of Research Excellence in Digestive Health, University of Newcastle, Newcastle, NSW, Australia.
  • Veysey M; College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia.
  • Holtmann G; Immune Health Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
  • Powell N; College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia.
  • Walker MM; Immune Health Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
  • Talley NJ; National Health & Medical Research Council (NHMRC) Centre of Research Excellence in Digestive Health, University of Newcastle, Newcastle, NSW, Australia.
  • Keely S; College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, NSW, Australia.
Front Immunol ; 13: 1051632, 2022.
Article in En | MEDLINE | ID: mdl-36685573
ABSTRACT

Background:

Functional dyspepsia is characterised by chronic symptoms of post-prandial distress or epigastric pain not associated with defined structural pathology. Increased peripheral gut-homing T cells have been previously identified in patients. To date, it is unknown if these T cells were antigen-experienced, or if a specific phenotype was associated with FD.

Objective:

This study aimed to characterise T cell populations in the blood and duodenal mucosa of FD patients that may be implicated in disease pathophysiology.

Methods:

We identified duodenal T cell populations from 23 controls and 49 Rome III FD patients by flow cytometry using a surface marker antibody panel. We also analysed T cell populations in peripheral blood from 37 controls and 61 patients. Where available, we examined the number of duodenal eosinophils in patients and controls.

Results:

There was a shift in the duodenal T helper cell balance in FD patients compared to controls. For example, patients had increased duodenal mucosal Th2 populations in the effector (13.03 ± 16.11, 19.84 ± 15.51, p=0.038), central memory (23.75 ± 18.97, 37.52 ± 17.51, p=0.007) and effector memory (9.80±10.50 vs 20.53±14.15, p=0.001) populations. Th17 populations were also increased in the effector (31.74±24.73 vs 45.57±23.75, p=0.03) and effector memory (11.95±8.42 vs 18.44±15.63, p=0.027) subsets. Peripheral T cell populations were unchanged between FD and control.

Conclusion:

Our findings identify an association between lymphocyte populations and FD, specifically a Th2 and Th17 signature in the duodenal mucosa. The presence of effector and memory cells suggest that the microinflammation in FD is antigen driven.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dyspepsia Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dyspepsia Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Australia